Company registration number 03533898 (England and Wales)
MATRIX SCIENCE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
MATRIX SCIENCE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
MATRIX SCIENCE LIMITED
BALANCE SHEET
AS AT 31 MARCH 2026
31 March 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
4
27,215
21,900
Investments
5
57,632
63,584
84,847
85,484
Current assets
Debtors
6
104,003
95,302
Cash at bank and in hand
344,082
229,103
448,085
324,405
Creditors: amounts falling due within one year
7
(193,322)
(273,900)
Net current assets
254,763
50,505
Total assets less current liabilities
339,610
135,989
Provisions for liabilities
(6,659)
(4,027)
Net assets
332,951
131,962
Capital and reserves
Called up share capital
106
106
Profit and loss reserves
332,845
131,856
Total equity
332,951
131,962
MATRIX SCIENCE LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2026
31 March 2026
- 2 -

For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 3 August 2026 and are signed on its behalf by:
Dr P A Emery
Mr V R Koskinen
Director
Director
Company registration number 03533898 (England and Wales)
MATRIX SCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
- 3 -
1
Accounting policies
Company information

Matrix Science Limited is a private company limited by shares incorporated in England and Wales. The registered office is 2nd Floor, 201 Haverstock Hill, Belsize Park, London, United Kingdom, NW3 4QG.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover comprises revenue recognised by the company in respect of service supplied during the year, exclusive of Value Added Tax and trade discounts. Turnover is recognised on a straight line basis over the period the customer subscribes to the company services. Any amounts invoiced in advance of the subscription period are carried forward as deferred income.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
20% on reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

MATRIX SCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 4 -

Investments in subsidiary undertakings are recognised at cost.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Where a reasonable and consistent basis of allocation can be identified, assets are allocated to individual cash-generating units, or otherwise they are allocated to the smallest group of cash-generating units for which a reasonable and consistent allocation basis can be identified.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Trade debtors are recognised and carried at original invoice amount less an allowance for any on-collectable amounts. An estimate for doubtful debts is made when collection of the full amount is no longer probable. Bad debts are written off when identified.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

MATRIX SCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 5 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.11
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Number
Number
Total
4
6
MATRIX SCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 6 -
4
Tangible fixed assets
Plant and equipment
£
Cost
At 1 April 2025
166,702
Additions
23,227
Disposals
(152,246)
At 31 March 2026
37,683
Depreciation and impairment
At 1 April 2025
144,802
Depreciation charged in the year
17,912
Eliminated in respect of disposals
(152,246)
At 31 March 2026
10,468
Carrying amount
At 31 March 2026
27,215
At 31 March 2025
21,900
5
Fixed asset investments
2026
2025
£
£
Shares in group undertakings and participating interests
57,632
63,584
Movements in fixed asset investments
Shares in subsidiaries
£
Cost or valuation
At 1 April 2025
63,584
Valuation changes
(5,952)
At 31 March 2026
57,632
Carrying amount
At 31 March 2026
57,632
At 31 March 2025
63,584
MATRIX SCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 7 -
6
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
73,218
59,745
Amounts owed by group undertakings
3,143
7,914
Other debtors
27,642
27,643
104,003
95,302
7
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
461
489
Taxation and social security
7,030
8,604
Other creditors
185,831
264,807
193,322
273,900
8
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

Marketing & Support expenses
Marketing & Support expenses
2026
2025
£
£
Entities over which the entity has control, joint control or significant influence
131,409
151,656

The following amounts were outstanding at the reporting end date:

2026
2025
Amounts due from related parties
£
£
Other related parties
3,143
7,913
2026-03-31 2025-04-01 false false false 03 August 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Dr P A Emery Mr Ville Rikhard Koskinen 03533898 2025-04-01 2026-03-31 03533898 2026-03-31 03533898 2025-03-31 03533898 core:PlantMachinery 2026-03-31 03533898 core:PlantMachinery 2025-03-31 03533898 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 03533898 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 03533898 core:CurrentFinancialInstruments 2026-03-31 03533898 core:CurrentFinancialInstruments 2025-03-31 03533898 core:ShareCapital 2026-03-31 03533898 core:ShareCapital 2025-03-31 03533898 core:RetainedEarningsAccumulatedLosses 2026-03-31 03533898 core:RetainedEarningsAccumulatedLosses 2025-03-31 03533898 bus:Director1 2025-04-01 2026-03-31 03533898 bus:Director2 2025-04-01 2026-03-31 03533898 core:PlantMachinery 2025-04-01 2026-03-31 03533898 2024-04-01 2025-03-31 03533898 core:PlantMachinery 2025-03-31 03533898 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 03533898 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 03533898 bus:FRS102 2025-04-01 2026-03-31 03533898 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 03533898 bus:FullAccounts 2025-04-01 2026-03-31 xbrli:pure xbrli:shares iso4217:GBP